Hendrik Jan Thibaut
Papers
1
Total Citations
14
H-Index
1
About
Hendrik Jan Thibaut is a leading virologist whose research focuses on antiviral drug discovery, with a particular emphasis on high-throughput screening (HTS) methodologies and emerging viral threats. His major contributions include the development of a robust, dual-reporter HTS assay for SARS-CoV-2, a critical tool that enabled rapid, automated screening of antiviral compounds during the pandemic. This work, published in 2022 and cited 14 times, exemplifies his commitment to creating practical, scalable solutions for urgent global health challenges. Thibaut’s research has significantly advanced the field by bridging the gap between basic virology and translational drug development, providing platforms that accelerate the identification of potential therapeutics. His innovative assay design—integrating dual reporters for enhanced reliability—has set a new standard for antiviral screening, impacting both academic and pharmaceutical efforts. Through his methodical approach and focus on robustness, Thibaut has established himself as a key figure in pandemic preparedness, demonstrating how thoughtful assay engineering can streamline the path from discovery to clinical application.
Research Focus
Key Achievements
Top Papers
- 1